LivaNova
LIVN
230 hedge funds and large institutions have $3.02B invested in LivaNova in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 87 increasing their positions, 80 reducing their positions, and 35 closing their positions.
9% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 80
6% more call options, than puts
Call options by funds: $27.9M | Put options by funds: $26.4M
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 35
0% less funds holding
Funds holding: 231 → 230 (-1)
3% less capital invested
Capital invested by funds: $3.12B → $3.02B (-$99.5M)
1.64% less ownership
Funds ownership: 103.3% → 101.65% (-1.6%)
Top Buyers
Top Sellers
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$60.7M |
| 2 |
DCM
DME Capital Management
New York
|
-$39.2M |
| 3 |
Barclays
London,
United Kingdom
|
-$31.7M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$31.6M |
| 5 |
CC
Clearline Capital
New York
|
-$27.9M |
LIVN Hedge Fund Activity: Q2 2024 in Review
230 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in LivaNova (LIVN) for Q2 2024, worth a combined $3.02B — down 3.2% from $3.12B a quarter earlier.
Fund positioning in LIVN was balanced in Q2 2024: 35 funds opened new positions, 35 closed out, 87 added to existing stakes and 80 trimmed.
The largest buyer was Capital Research Global Investors, opening a new position worth an estimated $65.8M. The largest seller was Barrow, Hanley, Mewhinney & Strauss, cutting an estimated $60.7M.
- 230 institutional investors held LivaNova (LIVN) as of Q2 2024, down from 231 in Q1 2024.
- Funds reported $3.02B of LivaNova stock for Q2 2024, down 3.2% quarter-over-quarter.
- 35 funds opened new LivaNova positions in Q2 2024 and 35 closed out, a net change of 0 holders.
- The largest LivaNova buyer in Q2 2024 was Capital Research Global Investors, an estimated $65.8M added.
- The largest LivaNova seller in Q2 2024 was Barrow, Hanley, Mewhinney & Strauss, an estimated $60.7M sold.
Based on aggregated 13F filings for Q2 2024.